A GHRH analog often asked with ipamorelin — not nominated, no lawful §503A pathway.
Oswego, Illinois · 74 W. Washington St · serving the Fox Valley. A licensed Illinois clinician still decides. Compounded medications are not FDA-approved.
Legal status reviewed July 2026 · Often asked with ipamorelin
What is CJC-1295 No DAC?
The molecule, in plain language.
CJC-1295 without DAC (sometimes discussed as a modified GRF 1-29) is a GHRH analog with a shorter activity window than the DAC version. It is a staple of online GH stacks. It is not something RE GEN can lawfully compound today.
How people usually take it. Not orderable.
What people are actually trying to solve.
Interest is not a result. We keep the research language and skip the miracle.
01
DAC vs no DAC, briefly
DAC (Drug Affinity Complex) extends half-life. “No DAC” is the shorter-acting analog people pulse. Neither version is orderable here.
·Different pharmacokinetics in research talk
·Same legal answer today
·See the With DAC page too
02
The stack is also blocked
CJC/ipamorelin 2X blends are not orderable.
·Ipamorelin has no pathway
·CJC-1295 has no pathway
·Sermorelin instead
03
What “not nominated” means
Without a monograph, approved-drug component, or 503A bulks-list placement, there is no bulk-eligibility gate to walk through.
·Absence of a ban is not a basis
·We will not compound it
·Status can change only with a real basis
What the evidence actually is — and what it isn’t.
A note on honesty: we will tell you what the literature supports and what it does not. Animal data is not a human guarantee. Anecdotes are not trials.
Animal research
Modified GRF analogs have preclinical GH-axis literature.
·Not 503A eligibility
·Not a clinic vial
·Do not confuse research catalogs with pharmacies
Human research
Limited clinical research does not create a compounding pathway at RE GEN.
·Not orderable
·No DIY reconstitution advice
·Read sermorelin
Legal basis at RE GEN · July 2026
We will not compound this today.
Not nominated / no lawful §503A pathway at this time. We will not compound CJC-1295 (with or without DAC).
We will not compound this. Ask us what is carried instead.
Peptide education for Illinois patients at RE GEN in Oswego — not a substitute for a visit.
What is CJC-1295 without DAC?
A shorter-acting GHRH analog in research and forum culture. Not orderable at RE GEN.
Is CJC-1295 without DAC FDA-approved?
CJC-1295 without DAC is not FDA-approved, and RE GEN does not have a lawful §503A pathway to request it as a compounded medication today. A committee vote is not approval.
Can I get CJC-1295 without DAC at RE GEN in Oswego?
You can start a visit to talk about your goal. We will not compound CJC-1295 without DAC today. We will show you what is carried instead — and we will say no rather than gray-market a vial.
Is the DAC version different legally?
No. Neither version has a lawful pathway here today.
Do you promise results?
No. Educational pages explain why people ask and what the research landscape looks like. Individual response varies. Compounded medications are not FDA-approved, and a request is not a guaranteed prescription.